{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:59:17Z","timestamp":1770753557527,"version":"3.50.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,10]]},"DOI":"10.7759\/cureus.103349","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:52:42Z","timestamp":1770731562000},"source":"Crossref","is-referenced-by-count":0,"title":["Short-Term Clinical and Immunologic Outcomes Conditional on SVR12 in Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Treated With Direct-Acting Antivirals: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Boonphiphop","family":"Boonpheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patompong","family":"Ungprasert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri C","year":"2004","unstructured":"Ferri C, Sebastiani M, Giuggioli D, et al.. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004, 33:355-74. 10.1016\/j.semarthrit.2003.10.001","journal-title":"Semin Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/2049936115585942","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"3","author":"Cacoub P","year":"2016","unstructured":"Cacoub P, Comarmond C, Domont F, Savey L, Desbois AC, Saadoun D. Extrahepatic manifestations of chronic hepatitis C virus infection. Ther Adv Infect Dis. 2016, 3:3-14. 10.1177\/2049936115585942","journal-title":"Ther Adv Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2400092","article-title":"Cryoglobulinemia - one name for two diseases","volume":"391","author":"Cacoub P","year":"2024","unstructured":"Cacoub P, Vieira M, Saadoun D. Cryoglobulinemia - one name for two diseases. N Engl J Med. 2024, 391:1426-39. 10.1056\/NEJMra2400092","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28297","article-title":"Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents","volume":"63","author":"Sise ME","year":"2016","unstructured":"Sise ME, Bloom AK, Wisocky J, et al.. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology. 2016, 63:408-17. 10.1002\/hep.28297","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208339","article-title":"Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study","volume":"75","author":"Saadoun D","year":"2016","unstructured":"Saadoun D, Thibault V, Si Ahmed SN, et al.. Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study. Ann Rheum Dis. 2016, 75:1777-82. 10.1136\/annrheumdis-2015-208339","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28753","article-title":"Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia","volume":"64","author":"Gragnani L","year":"2016","unstructured":"Gragnani L, Visentini M, Fognani E, et al.. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia. Hepatology. 2016, 64:1473-82. 10.1002\/hep.28753","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.49","article-title":"Efficacy and safety of direct acting antivirals for the treatment of mixed cryoglobulinemia","volume":"112","author":"Emery JS","year":"2017","unstructured":"Emery JS, Kuczynski M, La D, et al.. Efficacy and safety of direct acting antivirals for the treatment of mixed cryoglobulinemia. Am J Gastroenterol. 2017, 112:1298-308. 10.1038\/ajg.2017.49","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.09.158","article-title":"Virologic, clinical, and immune response outcomes of patients with hepatitis C virus-associated cryoglobulinemia treated with direct-acting antivirals","volume":"15","author":"Bonacci M","year":"2017","unstructured":"Bonacci M, Lens S, Londo\u00f1o MC, et al.. Virologic, clinical, and immune response outcomes of patients with hepatitis C virus-associated cryoglobulinemia treated with direct-acting antivirals. Clin Gastroenterol Hepatol. 2017, 15:575-583.e1. 10.1016\/j.cgh.2016.09.158","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11040984","article-title":"Persistence of cryoglobulinemic vasculitis after DAA induced HCV cure","volume":"11","author":"Danishwar M","year":"2022","unstructured":"Danishwar M, Jamil Z, Khan S, Nakhla M, Ahmad I, Ali MA, Lau DT. Persistence of cryoglobulinemic vasculitis after DAA induced HCV cure. J Clin Med. 2022, 11:984. 10.3390\/jcm11040984","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.04.024","article-title":"Long-term outcomes of patients with HCV-associated cryoglobulinemic vasculitis after virologic cure","volume":"155","author":"Bonacci M","year":"2018","unstructured":"Bonacci M, Lens S, Mari\u00f1o Z, et al.. Long-term outcomes of patients with HCV-associated cryoglobulinemic vasculitis after virologic cure. Gastroenterology. 2018, 155:311-315.e6. 10.1053\/j.gastro.2018.04.024","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27623","article-title":"Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study","volume":"61","author":"Gragnani L","year":"2015","unstructured":"Gragnani L, Fognani E, Piluso A, et al.. Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study. Hepatology. 2015, 61:1145-53. 10.1002\/hep.27623","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-025-09033-8","article-title":"Long term follow-up of patients with cryoglobulinemia after successful treatment of chronic C virus hepatitis","volume":"70","author":"Elthes BZ","year":"2025","unstructured":"Elthes BZ, Vitalis Z, Papp M, Tornai T, Tornai D, Tornai I. Long term follow-up of patients with cryoglobulinemia after successful treatment of chronic C virus hepatitis. Dig Dis Sci. 2025, 70:2467-74. 10.1007\/s10620-025-09033-8","journal-title":"Dig Dis Sci"},{"key":"ref13","article-title":"Birmingham vasculitis activity score, disease extent index and complement factor C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic vasculitis","volume":"18","author":"Lamprecht P","year":"2000","unstructured":"Lamprecht P, Moosig F, Gause A, Herlyn K, Gross WL. Birmingham vasculitis activity score, disease extent index and complement factor C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic vasculitis. Clin Exp Rheumatol. 2000, 18:319-25.","journal-title":"Clin Exp Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00808-1","article-title":"The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements","volume":"23","author":"Dammacco F","year":"2023","unstructured":"Dammacco F, Lauletta G, Vacca A. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements. Clin Exp Med. 2023, 23:255-72. 10.1007\/s10238-022-00808-1","journal-title":"Clin Exp Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001667","article-title":"Relapse of hepatitis C virus cryoglobulinemic vasculitis after sustained viral response after interferon-free direct-acting antivirals","volume":"117","author":"Fayed A","year":"2022","unstructured":"Fayed A, Hegazy MT, Biard L, et al.. Relapse of hepatitis C virus cryoglobulinemic vasculitis after sustained viral response after interferon-free direct-acting antivirals. Am J Gastroenterol. 2022, 117:627-36. 10.14309\/ajg.0000000000001667","journal-title":"Am J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32281","article-title":"A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort","volume":"76","author":"Kondili LA","year":"2022","unstructured":"Kondili LA, Monti M, Quaranta MG, et al.. A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort. Hepatology. 2022, 76:220-32. 10.1002\/hep.32281","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14053","article-title":"Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis","volume":"39","author":"Visentini M","year":"2019","unstructured":"Visentini M, Del Padre M, Colantuono S, et al.. Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis. Liver Int. 2019, 39:628-32. 10.1111\/liv.14053","journal-title":"Liver Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew268","article-title":"Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy","volume":"55","author":"Sollima S","year":"2016","unstructured":"Sollima S, Milazzo L, Peri AM, Torre A, Antinori S, Galli M. Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy. Rheumatology (Oxford). 2016, 55:2084-5. 10.1093\/rheumatology\/kew268","journal-title":"Rheumatology (Oxford)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.02.037","article-title":"Direct-acting antiviral therapy restores immune tolerance to patients with hepatitis C virus-induced cryoglobulinemia vasculitis","volume":"152","author":"Comarmond C","year":"2017","unstructured":"Comarmond C, Garrido M, Pol S, et al.. Direct-acting antiviral therapy restores immune tolerance to patients with hepatitis C virus-induced cryoglobulinemia vasculitis. Gastroenterology. 2017, 152:2052-62.e2. 10.1053\/j.gastro.2017.02.037","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1280-6","article-title":"Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience","volume":"19","author":"Lauletta G","year":"2017","unstructured":"Lauletta G, Russi S, Pavone F, Vacca A, Dammacco F. Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience. Arthritis Res Ther. 2017, 19:74. 10.1186\/s13075-017-1280-6","journal-title":"Arthritis Res Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.03.006","article-title":"Efficacy and safety of sofosbuvir plus daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis","volume":"153","author":"Saadoun D","year":"2017","unstructured":"Saadoun D, Pol S, Ferfar Y, et al.. Efficacy and safety of sofosbuvir plus daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis. Gastroenterology. 2017, 153:49-52.e5. 10.1053\/j.gastro.2017.03.006","journal-title":"Gastroenterology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S167093","article-title":"Sofosbuvir-daclatasvir improves hepatitis C virus-induced mixed cryoglobulinemia: Upper Egypt experience","volume":"11","author":"Hassan AM","year":"2018","unstructured":"Hassan AM, Osman HA, Mahmoud HS, Hassan MH, Hashim AA, Ameen HH. Sofosbuvir-daclatasvir improves hepatitis C virus-induced mixed cryoglobulinemia: Upper Egypt experience. Infect Drug Resist. 2018, 11:895-901. 10.2147\/IDR.S167093","journal-title":"Infect Drug Resist"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.05.021","article-title":"Long-term efficacy of interferon-free antiviral treatment regimens in patients with hepatitis C virus-associated cryoglobulinemia vasculitis","volume":"17","author":"Cacoub P","year":"2019","unstructured":"Cacoub P, Si Ahmed SN, Ferfar Y, et al.. Long-term efficacy of interferon-free antiviral treatment regimens in patients with hepatitis C virus-associated cryoglobulinemia vasculitis. Clin Gastroenterol Hepatol. 2019, 17:518-26. 10.1016\/j.cgh.2018.05.021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.823160","article-title":"Evolution of cryoglobulinemia in direct-acting antiviral-treated Asian hepatitis C patients with sustained virological responses: a 4-year prospective cohort study","volume":"13","author":"Chang ML","year":"2022","unstructured":"Chang ML, Cheng JS, Chuang YH, et al.. Evolution of cryoglobulinemia in direct-acting antiviral-treated Asian hepatitis C patients with sustained virological responses: a 4-year prospective cohort study. Front Immunol. 2022, 13:823160. 10.3389\/fimmu.2022.823160","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/464703-short-term-clinical-and-immunologic-outcomes-conditional-on-svr12-in-hepatitis-c-virus-associated-cryoglobulinemic-vasculitis-treated-with-direct-acting-antivirals-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:52:42Z","timestamp":1770731562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/464703-short-term-clinical-and-immunologic-outcomes-conditional-on-svr12-in-hepatitis-c-virus-associated-cryoglobulinemic-vasculitis-treated-with-direct-acting-antivirals-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.103349","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}